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Abstract
Background—Little is known about diet quality with a reduced-energy, low-fat, partial meal 
replacement (PMR) plan, especially in individuals with type 2 diabetes. The Action for Health in 
Diabetes (Look AHEAD) trial implemented a PMR plan in the intensive lifestyle intervention 
(ILI).
Objective—Compare dietary intake and percent meeting fat-related and food group dietary 
recommendations in ILI and diabetes support and education (DSE) groups at 12 months.
Design—Randomized controlled trial, comparing ILI to DSE, at 0- and 12-months.
Participants/setting—From 16 United States sites, the first 50% of participants (aged 45 to 76 
years, overweight or obese, with type 2 diabetes) were invited to complete dietary assessments. 
Complete 0- and 12-month dietary assessments (collected between 2001 and 2004) were available 
on 2,397 participants (46.6% of total participants), with 1,186 randomized to DSE and 1,211 
randomized to ILI.
Main outcome measures—A food frequency questionnaire assessed intake: energy; percent 
energy from protein, fat, carbohydrate, polyunsaturated fatty acids (PUFA), and saturated fats; 
trans fatty acids; cholesterol; fiber; weekly meal replacements (MRs); and daily servings from 
food groups from the Food Guide Pyramid.
Statistical analyses performed—Mixed-factor analyses of covariance (ANCOVA), using 
Proc MIXED with a repeated statement, with age, sex, race/ethnicity, education, and income 
controlled. Unadjusted chi-square tests compared percent meeting fat-related and food group 
recommendations at 12 months.
Results—At 12 months, ILI had a significantly lower fat and cholesterol intake and greater fiber 
intake than DSE. ILI consumed more servings/day of fruits; vegetables; and milk, yogurt & 
cheese; and fewer servings/day of fats, oils & sweets than DSE. A greater percentage of ILI than 
DSE participants met fat-related and most food group recommendations. Within ILI, a greater 
percentage of participants consuming ≥ 2 MRs/day than < 1 MR/day met most fat-related and food 
group recommendations.
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Conclusions—The PMR plan consumed by ILI was related to superior diet quality.
Keywords
Partial meal replacement plan; diet quality; Type 2 diabetes; lifestyle intervention
A partial meal replacement (PMR) plan contains two portioned-controlled, vitamin/mineral 
fortified meal replacements (MRs), usually beverages and food bars, per day and one 
balanced meal consisting of lower-energy, high-nutrient-dense, conventional foods.1 While 
a PMR plan has been found to be an efficacious strategy for weight loss,1 little is known 
about how a reduced-energy, low-fat, PMR plan influences diet quality, particularly in 
regards to meeting Dietary Guideline recommendations.2 Only three investigations have 
examined macro- and micronutrient intake of healthy obese older adults3 and healthy 
overweight and obese women4,5 prescribed a reduced-energy, low-fat, PMR plan. One 
investigation found lower total and saturated fat intake with the PMR plan in comparison to 
an attention control group,3 one investigation found lower total fat and cholesterol intake 
with the PMR plan in comparison to a reduced-energy, low-fat diet comprised of 
conventional foods,5 while all studies found greater key micronutrient intake (i.e., calcium, 
vitamin D, vitamin E, and Vitamin C) in the PMR plan as compared to either an attention 
control group3 or a reduced-energy, low-fat diet comprised of conventional foods.4,5 None 
of the studies examined overall food group intake or the percentage of participants meeting 
recommendations for food group intake when prescribed a reduced-energy, low-fat, PMR 
plan. Additionally, while diet quality of a PMR plan has been examined in healthy 
overweight and obese individuals, diet quality of a PMR plan has not been examined in 
individuals with type 2 diabetes.
The Action for Health in Diabetes (Look AHEAD) trial is a 16 center, randomized 
controlled trial, whose purpose was to investigate the influence of weight loss achieved via 
an intensive lifestyle intervention (ILI) on long-term cardiovascular health in overweight or 
obese adults with type 2 diabetes. There are two study arms in Look AHEAD: ILI, which 
focuses on weight loss through a lifestyle intervention, and a diabetes support and education 
(DSE) group that provides education on nutrition and physical activity and social support to 
participants.6,7 The 12-month changes in weight indicated that participants in ILI lost a 
significantly greater amount of their initial body weight than those in DSE (−8.6% ± 6.9% 
vs. −0.7% ± 4.8%).8 To achieve weight loss, ILI was prescribed a reduced-energy, low-fat 
diet, PMR plan. Thus, Look AHEAD provides an opportunity to examine diet quality in 
patients with type 2 diabetes consuming a PMR plan.
Therefore the aim of this investigation was to investigate diet changes in the ILI and DSE 
groups from 0- to 12-months and to examine diet quality at 12 months between the two 
groups. Furthermore within the ILI group, diet quality was examined in participants who 
self-reported consumption of meal replacements <1, 1 to < 2, or ≥2 MRs/day. Measures of 
diet quality included macronutrient and Food Guide Pyramid (FGP)9 food group intake. 
Percentage of participants at 12 months meeting fat, cholesterol, and minimum daily food 
FGP group serving recommendations of the 2000 Dietary Guidelines for Americans2 in each 
group, and in ILI by MR consumption category, was examined. These recommended 
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guidelines were used in this investigation as these were the guidelines in place during the 
first year of the Look AHEAD trial. Due to the previous findings related to macro- and 
micronutrient intake when a reduced-energy, low-fat, PMR is consumed, it was 
hypothesized that at 12 months, ILI would have a greater percentage of participants meeting 
fat-related and food group intake recommendations than DSE, and that in the ILI, a greater 
percentage of participants consuming ≥2 MRs/day as compared to the percentage of 
participants consuming < 1 MR/day would report meeting these same recommendations.
Methods
Research Design and Participants
Participants were recruited for Look AHEAD over 2.5 years beginning in 2001.7 Look 
AHEAD randomized 5,145 participants with type 2 diabetes aged 45–76 years (the age 
range was changed to 55–76 years in the second year of recruitment to increase the rate of 
anticipated cardiovascular events) with a body mass index (BMI) ≥ 25 kg/m2 (≥ 27 kg/m2 if 
taking insulin) and no upper limit for BMI.7 The goal of recruitment was to achieve equal 
numbers of men and women and a minimum of 33% of participants from racial/ethnic 
minority groups and to have ≤30% of participants taking insulin.7 Exclusion criteria 
included inadequate control of diabetes (i.e., A1C >11%), factors affecting a participant’s 
ability to adhere to interventions, and underlying diseases likely to limit life span and/or 
affect the safety of the interventions.7 Eligibility for Look AHEAD was determined using a 
series of screening visits. Additionally, potential participants completed a two-week run-in, 
in which food intake and physical activity was recorded for two weeks. Those potential 
participants who did not keep satisfactory records for at least 12 of 14 days were considered 
ineligible. All participants gave informed consent, consistent with the Helsinki Declaration 
and approved by the institutional review board of each center.
For this investigation, participants who completed the dietary assessment component of the 
trial at 0 and 12 months were included. At each site, the first 50% of participants assessed 
were asked to complete dietary assessments. At baseline, 2,973 dietary assessments were 
completed prior to randomization. Of the 2,397 with 0- and 12-month assessments, 1,186 
(49.5%) were randomized to DSE and 1,211 (50.5%) were randomized to ILI. Participants 
were provided $100 for completion of the 12-month follow-up.
Interventions
Following completion of baseline measures, participants were randomized to ILI or DSE. 
For ILI, in the first six months of the program participants were prescribed a low-energy 
(1200 to 1500 kcal/day for those < 113.6 kg, and 1500 to 1800 kcal/day for those ≥ 113.6 
kg), low-fat (< 30% kcal from fat, with < 10% from saturated fat) diet.6 The ILI prescription 
also included a PMR plan, in which for the first four months (weeks 3–19 of the trial), MRs 
(beverages and food bars) were recommended to be consumed to replace two meals per day 
and one or two snacks per day.10 The MRs were provided to participants. One meal was to 
be consumed from conventional foods, with an emphasis of adding fruits and vegetables to 
the diet.6 Starting week 20 until completion of the first year of the trial, participants were 
encouraged to replace one or two meals and snacks per day with MRs, with only one MR 
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per day provided to participants.10 Participants who refused MRs were provided detailed 
menu plans that specified amounts of conventional foods to be consumed.6 ILI also received 
a physical activity goal of 175 minutes of moderate-intensity physical activity per week. 
During the first six months of the program participants in the ILI attended three group 
sessions per month, in which lifestyle modification topics and techniques were presented, 
and received one individual session per month.6,7 During months 7 to 12, participants 
received two group sessions and one individual session per month.6,7 Participants in ILI 
self-monitored their energy and fat gram intake daily via a food diary. Diaries were 
reviewed by intervention staff, which included registered dietitians, so that feedback could 
be provided to participants to assist them in meeting the dietary prescription.
If participants in the ILI were unsuccessful at meeting diet and physical activity goals and 
thus had lower weight loss than expected, a toolbox approach was implemented to assist 
these participants in meeting goals.6 The toolbox was composed of advanced behavioral 
strategies (i.e., provision of exercise equipment, enrolling participants in a supervised 
exercise program or a cooking class, etc.) and the weight loss medication orlistat. Selection 
of a particular strategy was individualized and designed to address the barriers experienced 
by the participant, using a series of algorithms. Use of orlistat was closely monitored. When 
using orlistat, it is recommended that foods high in fat are avoided. Orlistat was offered as 
an option to participants if after the first six months they had lost < 5% or ≥ 5% but < 10% 
of initial weight. Additionally, participants who had lost ≥ 10% of initial weight but after six 
months had regained ≥ 2% were offered the option of using orlistat. Participants who took 
orlistat were monitored by a study physician or nurse practitioner.
The DSE group received general information on dietary intake and physical activity via 
three group sessions per year.7 The DSE group received no counseling regarding behavior 
modification for changing dietary intake, increasing physical activity, or losing weight.7
Measures
Sociodemographic and anthropometric characteristics—Self-reported 
information on age, sex, race/ethnicity, highest level of education, and annual household 
income was collected from participants. BMI was calculated as body weight in kilograms 
divided by the square of height in meters, with height measured by a wall-mounted 
stadiometer (Seca 214, Seca North America East, Hanover, MD) and weight measured by 
electronic scale (Tanita, model BWB-800, Willobrook, IL). Both measures were performed 
with outer garments (coats, jackets, sweaters) removed and without shoes.
Dietary assessment—For the Look AHEAD Trial, a semi-quantitative, food frequency 
questionnaire (FFQ) was utilized to assess dietary intake. This FFQ was a modified version 
of the Diabetes Prevention Program (DPP) FFQ11–13 and measured usual intake over the 
previous six months. The DPP food list, designed to enhance sensitivity to regional and 
ethnic food choices,12 served as a basis of the food list in the Look AHEAD FFQ. The FFQ 
contained 134 line items, 20 items that can be used to adjust the 134 main items (i.e., type of 
oil used when cooking, fat added to vegetables, etc.), and three quality control questions. As 
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the ILI prescribed the use of MRs, MR beverages and food bars were added as line items to 
the FFQ.
For each line item, respondents reported their frequency of consumption and portion size 
consumed. The nine frequency categories for food items ranged from “never or less than 
once per month” to “2 or more times per day.” The nine frequency categories for beverages 
ranged from “never or less than once per month” to “6 or more times per day.” Portion sizes 
were listed as small, medium, or large.
Participants responded to additional questions about how frequently they consumed low-fat 
versions of 10 foods: meat, bacon/sausage, burritos, cookies/cake, cheese, snack, lunch 
meats, pizza, spaghetti, and yogurt. Frequency categories were: “I do not eat the foods,” 
“seldom/never,” “sometimes,” and “often/always.”
Participants were provided instructions on how to complete the FFQ. Following its 
completion, the questionnaire was reviewed by a staff member, blinded to randomization, 
for errors and completeness.
Management of the dietary assessment for the Look AHEAD trial was centralized at the 
Look AHEAD Diet Assessment Center (DAC), located at the University of South Carolina, 
Columbia, SC. One primary diet interviewer for each site was certified by DAC staff to 
administer and review the FFQ. Certification of this interviewer was conducted annually. 
The FFQs were reviewed initially at each site, and additional editing and quality control 
checks (i.e., internal consistency and range) were performed at the DAC using the edit 
checks in the National Cancer Institute Health Habits and History Questionnaire HHHQ/
DietSys program (version 3.0, 1993, National Cancer Institute, Rockville, MD), followed by 
a DAC staff review if a food or nutrient value was found to be extreme.
Daily dietary estimates of food group and nutrient intake were determined using the HHQ/
DietSys software and Look AHEAD specific programming that incorporated the specific 
Look AHEAD modifications to the FFQ. The nutrient database that was utilized was 
modified from the DPP database so that foods added to the Look AHEAD FFQ (i.e., MRs) 
could be incorporated. For MRs, a total of 38 beverages and 86 food bars were identified as 
consumed by participants. A cluster analyses was conducted and three macronutrient 
composition clusters, three for beverages and three for food bars, emerged. For beverages 
the three macronutrient composition clusters were: 1) 13.0% energy from fat, 70.6% energy 
from carbohydrate, and 18.7% energy from protein; 2) 37.9% energy from fat, 48.2% energy 
from carbohydrate, and 17.3% energy from protein; and 3) 26.9% energy from fat, 24.9% 
energy from carbohydrate, and 50.1% energy from protein. For food bars the three 
macronutrient composition clusters were: 1) 25.5% energy from fat, 61.4% energy from 
carbohydrate, and 16.4% energy from protein; 2) 14.4% energy from fat, 75.0% energy from 
carbohydrate, and 15.0% energy from protein; and 3) 26.2% energy from fat,40.9% energy 
from carbohydrate, and 33.9% energy from protein. All individual MR’s energy (on average 
each MR was approximately 180 kcal) and macronutrient composition was coded according 
to the appropriate cluster. Nutrient values were obtained from the Nutrition Data System 
(NDS-R) Nutrition Coordinating Center, University of Minnesota, Minneapolis, MN 
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(version 4.01_30, 1999). The portion size database (gram weights for small, medium, and 
large portions based upon sex and age) was also modified to incorporate the new foods on 
the Look AHEAD FFQ. Food group servings were based upon the FGP,9 and MRs were 
coded as milk, yogurt & cheese (beverage) and meat, poultry, fish, dry beans, eggs & nuts 
(food bars).
Primary dietary variables—Primary dietary variables measured at 0 and 12 months 
included: energy in kilocalories per day (kcal/day); percent energy from protein, fat, 
carbohydrate, polyunsaturated fatty acids (PUFA), and saturated fats; trans fatty acids in 
grams per day (g/day); cholesterol in milligrams per day (mg/day); dietary fiber in grams per 
day (g/day); and number of weekly MRs consumed. Food group consumption based on the 
FGP was measured by the number of daily servings at 0 and 12 months.
Additionally, changes in frequency of consumption of low-fat versions of the 10 additional 
foods listed on the FFQ were examined. Changes in frequency of consumption were 
calculated as increasing in frequency (changing from seldom/never to sometimes or often/
always, or changing from sometimes to often/always), decreasing in frequency (changing 
from often/always to sometimes or seldom/never, or changing from sometimes to seldom/
never), or not changing in frequency from 0 to 12 months.
The percentage of participants meeting the following guidelines were calculated for analysis 
from 12-month data: 1) ≤ 30% energy from fat; 2) ≤ 10% energy from saturated fat; and 3) < 
300 mg/day of cholesterol. The percentage of participants meeting the minimum 
recommended number of daily servings from each food group (bread, cereal, rice & pasta; 
fruit; vegetable; milk, yogurt & cheese; meat, poultry, fish, dry beans, eggs & nuts; and fats, 
oils & sweets) from the FGP was also calculated at 12 months.2 Finally, participants in the 
ILI group were divided into one of three groups based upon MR consumption: <1/day, 1 to 
< 2/day, and ≥ 2/day. The percentage of participants in each MR group who met the 
guidelines at 12 months was assessed.
Statistical Analysis
Chi-square tests and independent t-tests were used to assess differences in baseline 
characteristics between excluded and included patients and between the two intervention 
groups. Several dietary variables, energy, trans fatty acids, fiber, MRs, and daily servings 
consumed from all food groups, were not normally distributed; thus, log transformations 
were used to normalize the distribution of these variables. Mixed-factor analyses of 
covariance (ANCOVA), with a between-subject factor of group (ILI vs. DSE) and within-
subject factor of time (0 and 12 months), with age, sex, race/ethnicity, education, and 
income controlled, using Proc MIXED with a repeated statement, were conducted to 
examine change in the primary dependent variables of interest. The primary dependent 
variables examined in these analyses were energy; percent energy from fat, carbohydrate, 
protein, PUFA, and saturated fat; trans fatty acid; cholesterol; fiber; and weekly MR intake. 
Similar analyses were performed to determine changes in daily servings consumed from 
food groups from the FGP. For assessing the consumption of low-fat versions of the 10 
additional foods listed on the FFQ, change in frequency of consumption from 0 to 12 
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months was categorized as “increased,” “decreased,” or “no change.” Unadjusted chi-square 
tests were used to assess for differences between ILI and DSE in changes in frequency of 
consumption of low-fat food items and percentage meeting recommended guidelines, and 
for ILI differences by MR consumption in percentage meeting recommended guidelines. 
Differences in least squares means were assessed when the adjusted time by group 
interactions was significant. Data are reported as mean and standard deviation (SD): mean 
(SD). All analyses were conducted using SAS v9.1 (Cary, NC), using an alpha level of ≤ 
0.05 for significance.
Results
Comparisons were made between Look AHEAD participants with 0- and 12-month data and 
who had dietary data and thus were included in this investigation (n = 2,397) and who did 
not have dietary data and thus were not included in this investigation (n = 2,505). Significant 
differences were found in age (included = 57.2 [7.2] yrs vs. not included = 60.2 [6.1] yrs, p 
< 0.001), race (included = 13.8% African-American vs. not included = 17.2% African-
American, p < 0.05) and annual household income (included = 31.5% <$40,000 vs. not 
included = 35.7% <$40,000, p < 0.01). Due to the change in age eligibility criteria after the 
first year, additional analyses were conducted to determine if there were differences in age 
in those included and those not included in the analyses in the first year and remaining years 
in which randomization occurred. Independent t-tests showed that there was no significant 
difference in age in the first year (included [n=1776] = 56.3 [7.2] yrs vs. not included 
[n=252] = 56.8 [7.7] yrs). In the remaining years of randomization, those included in the 
analyses (n = 618) were significantly younger than those not included (n = 2253) (59.6 [6.5] 
yrs vs 60.6 [5.8] yrs, p < 0.001). No differences were found in participants included and not 
included in the investigation in BMI, sex, and education.
Baseline characteristics of the participants included in the analyses are shown in Table 1. 
Participants were 59.2% female, 64.8% non-Hispanic White, with a mean age of 57.2 (7.2) 
yrs, and a mean BMI of 36.1 (6.0) kg/m2. Additionally, 79.5% had some college education 
and 39.7% had a yearly income of ≥ $70,000. There were no significant differences between 
the two groups on any of these characteristics (p > 0.20). During months 7 to 12, 263 
(21.7%) of participants in ILI used orlistat.
Energy; percent energy from carbohydrate, fat, protein, PUFA, and saturated fat; trans fatty 
acids; cholesterol; fiber; and weekly MR intake, at 0 and 12 months in the two groups are 
shown in Table 2. There were no differences at 0 months between the groups on any of these 
dietary variables. For both energy and percent energy from protein intake, there was a 
significant main effect of time, with both groups reducing energy intake (ILI: −331 [760] 
kcal/day; DSE: −310 [750] kcal/day) and increasing percent energy from protein over time 
(ILI: +0.9 [3.0] %; DSE: +0.7 [3.2] %) (p < 0.0001). All other nutrients showed significant 
interactions of group x time (p < 0.0001). For percent energy from fat, saturated fat and 
PUFA; trans fatty acids; and cholesterol intake, ILI showed greater decreases over time, and 
at 12 months ILI had a significantly lower intake than DSE (p < 0.0001). ILI showed a 
greater increase in percent energy from carbohydrate and dietary fiber intake, as ILI had a 
significantly greater intake at 12 months than DSE (p < 0.0001).
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MR consumption also demonstrated a significant group x time interaction (p < 0.0001) (see 
Table 2). There were no differences in intake between the groups at 0 months, but at 12 
months ILI had increased consumption and reported greater weekly intake of MRs than DSE 
(13.5 [10.7] MRs/week vs. 1.5 [4.1] MRs/week, p < 0.0001).
Consumption of daily servings of food groups from the FGP for ILI and DSE at 0 and 12 
months is shown in Table 3. There were no significant differences between the groups in 
food group intake at month 0. There was a significant group x time interaction for daily 
servings from the bread, cereal, rice & pasta; fruit; vegetable; milk, yogurt & cheese; meat, 
poultry, fish, dry beans, eggs & nuts; and fats, oils & sweets groups (p < 0.0001). ILI 
showed a decrease over time in consumption of daily servings from the bread, cereal, rice & 
pasta; meat, poultry, fish, dry beans, eggs & nuts; and fats, oils & sweets groups, and at 12 
months, ILI consumed significantly fewer daily servings from these food groups than DSE 
(p < 0.0001). Additionally, ILI increased intake of daily servings from the fruit; vegetable; 
and milk, yogurt & cheese groups, and at 12 months ILI consumed significantly more daily 
servings from these food groups than DSE (p < 0.0001).
Change in frequency of consumption of low-fat versions of the additional foods was 
significant for 9 out of the 10 food items, with ILI reporting a larger percentage of 
participants increasing their frequency of consumption of the low-fat versions from 0 to 12 
months than DSE (p < 0.01) (see Figure 1). The only low-fat version of food that was not 
significantly different between the two groups was low-fat meat.
Percentage of participants in ILI and DSE meeting recommendations at 12 months is shown 
in Table 4. A significantly higher percentage of ILI participants than DSE met the guidelines 
for percent energy from fat and saturated fat, and cholesterol, as well as for the fruit; 
vegetable; milk, yogurt & cheese; and fats, oils & sweets food group intake (p < 0.0001). A 
significantly greater percentage of DSE participants met the recommendations for bread, 
cereal, rice & pasta; and meat, poultry, fish, dry beans, eggs & nuts food group intake than 
ILI (p < 0.0001).
Table 5 shows the percentage of participants in the MR categories in the ILI group meeting 
recommendations at 12 months. There was no difference in percentage of participants in the 
MR categories using orlistat during months 7 to 12. Except for the recommendations for 
bread, cereal, rice & pasta and meat, poultry, fish, dry beans, eggs & nuts, a significantly 
greater percentage of participants consuming ≥ 2 MRs/day met all other recommendations, 
followed by participants consuming 1 to < 2 MRs/day and < 1 MR/day, respectively (p < 
0.05). When participants in the MR categories using orlistat during months 7 to 12 were 
removed from the analyses, a significantly greater percentage of participants consuming > 2 
MRs/day met the same recommendations, followed by participants consuming 1 to < 2 
MRs/day and < 1 MR/day, as the initial analyses (results of analyses not shown) (p < 0.05).
Discussion
This study was the first investigation to assess diet quality and food group consumption for 
individuals with type 2 diabetes who were prescribed a reduced energy, low-fat, PMR plan. 
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With the implementation of the PMR plan, ILI reported lower consumption of percent 
energy from fat, saturated fat and PUFA; trans fatty acids; and cholesterol, and greater 
consumption of fiber than DSE at 12 months. For intake from food groups from the FGP at 
12 months, ILI reported a greater daily serving intake from the fruit; vegetable; and milk, 
yogurt & cheese groups, and fewer daily serving intake from the fat, oils & sweets group 
than DSE. Other measures of self-reported fat intake, frequency of consumption of low-fat 
versions of food, also indicated that ILI participants made greater reductions in fat intake 
than DSE at 12 months. This suggests enhancement in overall diet quality in ILI. As slightly 
over 20% of participants in ILI used orlistat during months 7 to 12, this may have also 
contributed to fat intake differences between ILI and DSE.
At baseline, in regards to recommendations for percent energy from fat (≤ 30%) and 
saturated fat (≤10%) intake, daily cholesterol consumption (≤ 300 mg/day), and food group 
intake as provided from the 2000 Dietary Guidelines for Americans,2 most Look AHEAD 
participants’ diets did not meet recommendations (7%, 15%, 51%, 36%, 38%, 40%, and 
28% met the fat; saturated fat; cholesterol; and daily servings from the fruit; vegetable; milk, 
yogurt & cheese; and fats, oils & sweets group recommendations, respectively).14 At 12 
months, a significantly greater percentage of ILI participants met recommendations for 
percent energy from fat and saturated fat; cholesterol; and daily servings from the fruit; 
vegetable; milk, yogurt & cheese; and fats, oils & sweets food groups (29%, 51%, 80%, 
46%, 47%, 72%, and 60%, respectively) than DSE. Furthermore, when ILI participants were 
categorized by number of MRs consumed per day at 12 months, the greatest percentage of 
participants meeting dietary recommendations, excluding the recommendations for bread, 
cereal, rice & pasta and meat, poultry, fish, dry beans, eggs & nuts, were those consuming ≥ 
2 MRs/day, following by those consuming 1 to < 2 MR/day and < 1 MR/day, respectively. 
These results were consistent when participants in ILI using orlistat were removed from 
analyses. As most MRs were low in energy from fat, and beverage MRs contributed to the 
milk, yogurt & cheese food group, greater consumption of MRs, and in particular beverage 
MRs, could have assisted ILI participants meet these recommendations.
The findings that consuming a reduced-energy, low-fat PMR plan is associated with 
improved diet quality is similar to what has been found in three other investigations that 
have examined changes in diet quality with a PMR plan in healthy overweight and obese 
participants.3–5 Similarly to this investigation, Miller found lower total and saturated fat 
intake with the PMR plan in comparison to an attention control comparison,3 while Tovar 
and colleagues found lower fat intake with the PMR plan in comparison to a reduced-
energy, low-fat diet comprised of conventional foods.5 The present study, however, is the 
first to report on diet quality with a PMR plan in regards to food group consumption and in 
individuals with type 2 diabetes. It is important to note that ILI participants who report 
greater consumption of MRs also report greater minutes of moderate-intensity physical 
activity and attendance to intervention sessions.15 Thus in this investigation, greater 
consumption of MRs may be an indicator of engagement in healthy behaviors as a whole, 
which may include dietary choices that improve dietary quality.
In this investigation both ILI and DSE self-reported a decrease in energy intake of 
approximately 300 kcal/day from 0 to 12 months, but only ILI had a significant reduction in 
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percent body weight.8 This difference in weight loss without a difference in energy intake 
between the two groups may reflect greater inaccuracies in reporting in the DSE group. The 
lack of a difference in self-reported energy intake in ILI vs. DSE, despite large differences in 
weight loss, may reflect the use of MRs and the training which ILI received in portion 
estimation and self-monitoring. As MRs have shown to produce better weight loss outcomes 
than prescribed hypocaloric diets of conventional foods,1 and a proposed reason for this is 
better portion control (i.e., MRs reduce the error in monitoring intake due to automatic 
portion control),16 the greater use of MRs by ILI might have increased accuracy of reporting 
energy intake than DSE at 12-months. Similarly, the ILI group was encouraged to weigh 
foods and accurately monitor portion sizes. Thus, the reported energy intake in the ILI group 
at 12 months may be more accurate than the DSE group. Finally, receiving nutrition 
education may also influence reporting of dietary intake, irrespective of behavior change, 
with reported intake more closely matching the education received.17 Thus, the reporting of 
a lower energy intake in the DSE group, without the occurrence of weight loss, may be a 
consequence of the nutrition education provided to DSE.
The similar findings between changes in energy intake in the two groups at 12-months, 
despite differences in weight loss outcomes, highlights the challenges of accurately 
assessing dietary intake with self-reported measures. While the U.S. Department of 
Agriculture 5-pass method, 24-hour dietary recall is considered to be the gold standard of 
dietary assessment,18,19 in large samples FFQs are usually used to assess dietary intake over 
a specified time period due to their low cost and ease of administration.20 Furthermore due 
to its self-report nature, it is recognized that under-reporting of dietary intake is fairly 
common, particularly in individuals who are overweight,21–24 have diabetes,24 and want to 
reduce their weight. 22 While a version of this FFQ has been used previously and did show 
significant differences in energy intake across a 12-month period in randomized groups that 
received different dietary prescriptions,12 other research suggests that while self-reported 
energy intake from FFQs may contain errors, macronutrient reporting, particularly that 
adjusted for energy intake (i.e., percent energy from macronutrients or gram intake of 
macronutrients per 1000 kcal), may be less prone to reporting-error.25 This suggests that the 
findings of changes in relative intake of macronutrients may be more accurate than changes 
in absolute energy intake. As for food group intake, under-reporters general report 
consuming a greater amount of healthier foods (i.e., fruits and vegetables) and consuming 
fewer less healthy foods (i.e., pastries) than plausible reporters.26 Thus, while under-
reporting may have occurred in both groups, if there was greater under-reporting in DSE 
than ILI, diet quality of the DSE group may be lower than what is reported, suggesting an 
even greater difference in diet quality between the groups than what is described.
Strengths of the study include a large and racially- and ethnically-diverse sample, and the 
use of a valid and reliable FFQ designed to assess consumption of foods commonly eaten by 
the diverse sample. Limitations of the study relate to the self-reported nature of dietary 
assessment, and the lack of biomarkers to help validate dietary intake. The change in age 
eligibility after the first year of the investigation also produced a slightly younger sample, as 
compared to Look AHEAD participants not included in this investigation, from which the 
dietary assessments were conducted. The sample in this investigation also had a smaller 
percentage of African American participants and households with <$40,000 annual income 
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than Look AHEAD participants not included in this investigation. These demographic 
differences in this sample provide some indication of potential sampling bias from the 
overall Look AHEAD sample, which may influence outcomes. The impact of changes in 
physical activity on diet quality was also not able to be examined in this sample. 
Additionally, a study design allowing comparisons between a reduced-energy, low-fat diet 
composed of conventional foods and a reduced-energy, low-fat, PMR plan would enhance 
understanding about how MR consumption itself affects diet quality.
Conclusion and Application
This investigation found after 12 months of following a reduced-energy, low-fat, PMR plan, 
a greater proportion of ILI participants were meeting overall dietary recommendations 
related to fat, cholesterol, and food group intake. Additionally, within ILI, a greater 
proportion of participants consuming ≥ 2 MRs/day than < 1 MR/day were meeting dietary 
recommendations. Thus, for individuals with type 2 diabetes for whom weight loss has been 
recommended, a PMR plan may assist with weight loss and improve overall diet quality.
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This report represents a further analysis of the first year weight losses in the Look AHEAD 
study. It was prepared by the authors on behalf of the Look AHEAD Research Group. 
Members of the research group who participated in the recruitment, assessment, treatment, 
and retention of participants during the first year of the study are shown below:
Clinical Sites
The Johns Hopkins Medical Institutions Frederick L. Brancati, MD, MHS1; Jeff Honas, 
MS2; Lawrence Cheskin, MD3; Jeanne M. Clark, MD, MPH3; Kerry Stewart, EdD3; 
Richard Rubin, PhD3; Jeanne Charleston, RN; Kathy Horak, RD.
Pennington Biomedical Research Center George A. Bray, MD1; Kristi Rau2; Allison Strate, 
RN2; Brandi Armand, LPN2; Frank L. Greenway, MD3; Donna H. Ryan, MD3; Donald 
Williamson, PhD3; Amy Bachand; Michelle Begnaud; Betsy Berhard; Elizabeth Caderette; 
Barbara Cerniauskas; David Creel; Diane Crow; Helen Guay; Nancy Kora; Kelly LaFleur; 
Kim Landry; Missy Lingle; Jennifer Perault; Mandy Shipp, RD; Marisa Smith; Elizabeth 
Tucker.
The University of Alabama at Birmingham Cora E. Lewis, MD, MSPH1; Sheikilya Thomas 
MPH2; Monika Safford, MD3; Vicki DiLillo, PhD; Charlotte Bragg, MS, RD, LD; Amy 
Dobelstein; Stacey Gilbert, MPH; Stephen Glasser, MD; Sara Hannum, MA; Anne Hubbell, 
MS; Jennifer Jones, MA; DeLavallade Lee; Ruth Luketic, MA, MBA, MPH; Karen 
Marshall; L. Christie Oden; Janet Raines, MS; Cathy Roche, RN, BSN; Janet Truman; Nita 
Webb, MA; Audrey Wrenn, MAEd.
Harvard Center Massachusetts General Hospital: David M. Nathan, MD1; Heather Turgeon, 
RN, BS, CDE2; Kristina Schumann, BA2; Enrico Cagliero, MD3; Linda Delahanty, MS, 
RD3; Kathryn Hayward, MD3; Ellen Anderson, MS, RD3; Laurie Bissett, MS, RD; Richard 
Ginsburg, PhD; Valerie Goldman, MS, RD; Virginia Harlan, MSW; Charles McKitrick, RN, 
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Barbara Steiner, EdM; Joclyn Tosch, BA. Joslin Diabetes Center: Edward S. Horton, MD1; 
Sharon D. Jackson, MS, RD, CDE2; Osama Hamdy, MD, PhD3; A. Enrique Caballero, 
MD3; Sarah Bain, BS; Elizabeth Bovaird, BSN, RN; Ann Goebel-Fabbri, PhD; Lori 
Lambert, MS, RD; Sarah Ledbury, MEd, RD; Maureen Malloy, BS; Kerry Ovalle, MS, 
RCEP, CDE. Beth Israel Deaconess Medical Center: George Blackburn, MD, PhD1; 
Christos Mantzoros, MD, DSc3; Kristinia Day, RD; Ann McNamara, RN.
University of Colorado Health Sciences Center James O. Hill, PhD1; Marsha Miller, MS, 
RD2; JoAnn Phillipp, MS2; Robert Schwartz, MD3; Brent Van Dorsten, PhD3; Judith 
Regensteiner, PhD3; Salma Benchekroun MS; Ligia Coelho, BS; Paulette Cohrs, RN, BSN; 
Elizabeth Daeninck, MS, RD; Amy Fields, MPH; Susan Green; April Hamilton, BS, CCRC; 
Jere Hamilton, BA; Eugene Leshchinskiy; Michael McDermott, MD; Lindsey Munkwitz, 
BS; Loretta Rome, TRS; Kristin Wallace, MPH; Terra Worley, BA.
Baylor College of Medicine John P. Foreyt, PhD1; Rebecca S. Reeves, DrPH, RD2; Henry 
Pownall, PhD3; Ashok Balasubramanyam, MBBS3; Peter Jones, MD3; Michele Burrington, 
RD; Chu-Huang Chen, MD, PhD3; Allyson Clark, RD; Molly Gee, MEd, RD; Sharon 
Griggs; Michelle Hamilton; Veronica Holley; Jayne Joseph, RD; Patricia Pace, RD: Julieta 
Palencia, RN; Olga Satterwhite, RD; Jennifer Schmidt; Devin Volding, LMSW; Carolyn 
White.
University of California at Los Angeles School of Medicine Mohammed F. Saad, MD1; 
Siran Ghazarian, MD2; Ken C. Chiu, MD3; Medhat Botrous; Michelle Chan, BS; Kati 
Konersman, MA, RD, CDE; Magpuri Perpetua, RD.
The University of Tennessee Health Science Center University of Tennessee East. Karen C. 
Johnson, MD, MPH1; Carolyn Gresham, RN2; Stephanie Connelly, MD, MPH3; Amy 
Brewer, RD, MS; Mace Coday, PhD; Lisa Jones, RN; Lynne Lichtermann, RN, BSN; 
Shirley Vosburg, RD, MPH; and J. Lee Taylor, MEd, MBA. University of Tennessee 
Downtown. Abbas E. Kitabchi, PhD, MD1; Helen Lambeth, RN, BSN2; Debra Clark, LPN; 
Andrea Crisler, MT; Gracie Cunningham; Donna Green, RN; Debra Force, MS, RD, LDN; 
Robert Kores, PhD; Renate Rosenthal PhD; Elizabeth Smith, MS, RD, LDN; and Maria 
Sun, MS, RD, LDN; and Judith Soberman, MD3.
University of Minnesota Robert W. Jeffery, PhD1; Carolyn Thorson, CCRP2; John P. 
Bantle, MD3; J. Bruce Redmon, MD3; Richard S. Crow, MD3; Scott Crow, MD3; Susan K 
Raatz, PhD, RD3; Kerrin Brelje, MPH, RD; Carolyne Campbell; Jeanne Carls, MEd; Tara 
Carmean-Mihm, BA; Emily Finch, MA; Anna Fox, MA; Elizabeth Hoelscher, MPH, RD, 
CHES; La Donna James; Vicki A. Maddy, BS, RD; Therese Ockenden, RN; Birgitta I. Rice, 
MS, RPh CHES; Tricia Skarphol, BS; Ann D. Tucker, BA; Mary Susan Voeller, BA; Cara 
Walcheck, BS, RD.
St. Luke’s Roosevelt Hospital Center Xavier Pi-Sunyer, MD1; Jennifer Patricio, MS2; 
Stanley Heshka, PhD3; Carmen Pal, MD3; Lynn Allen, MD; Diane Hirsch, RNC, MS, CDE; 
Mary Anne Holowaty, MS, CN.
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University of Pennsylvania Thomas A. Wadden, PhD1; Barbara J. Maschak-Carey, MSN, 
CDE2; Stanley Schwartz, MD3; Gary D. Foster, PhD3; Robert I. Berkowitz, MD3; Henry 
Glick, PhD3; Shiriki K. Kumanyika, PhD, RD, MPH3; Johanna Brock; Helen 
Chomentowski; Vicki Clark; Canice Crerand, PhD; Renee Davenport; Andrea Diamond, 
MS, RD; Anthony Fabricatore, PhD; Louise Hesson, MSN; Stephanie Krauthamer-Ewing, 
MPH; Robert Kuehnel, PhD; Patricia Lipschutz, MSN; Monica Mullen, MS, RD; Leslie 
Womble, PhD, MS; Nayyar Iqbal, MD.
University of Pittsburgh David E. Kelley, MD1; Jacqueline Wesche-Thobaben, RN, BSN, 
CDE2; Lewis Kuller, MD, DrPH3; Andrea Kriska, PhD3; Janet Bonk, RN, MPH; Rebecca 
Danchenko, BS; Daniel Edmundowicz, MD3; Mary L. Klem, PhD, MLIS3; Monica E. 
Yamamoto, DrPH, RD, FADA 3; Barb Elnyczky, MA; George A. Grove, MS; Pat Harper, 
MS, RD, LDN; Janet Krulia, RN, BSN, CDE; Juliet Mancino, MS, RD, CDE, LDN; Anne 
Mathews, MS, RD, LDN; Tracey Y. Murray, BS; Joan R. Ritchea; Jennifer Rush, MPH; 
Karen Vujevich, RN-BC, MSN, CRNP; Donna Wolf, MS.
The Miriam Hospital/Brown Medical School Rena R. Wing, PhD1; Renee Bright, MS2; 
Vincent Pera, MD3; John Jakicic, PhD3; Deborah Tate, PhD3; Amy Gorin, PhD3; Kara 
Gallagher, PhD3; Amy Bach, PhD; Barbara Bancroft, RN, MS; Anna Bertorelli, MBA, RD; 
Richard Carey, BS; Tatum Charron, BS; Heather Chenot, MS; Kimberley Chula-Maguire, 
MS; Pamela Coward, MS, RD; Lisa Cronkite, BS; Julie Currin, MD; Maureen Daly, RN; 
Caitlin Egan, MS; Erica Ferguson, BS, RD; Linda Foss, MPH; Jennifer Gauvin, BS; Don 
Kieffer, PhD; Lauren Lessard, BS; Deborah Maier, MS; JP Massaro, BS; Tammy Monk, 
MS; Rob Nicholson, PhD; Erin Patterson, BS; Suzanne Phelan, PhD; Hollie Raynor, PhD, 
RD; Douglas Raynor, PhD; Natalie Robinson, MS, RD; Deborah Robles; Jane Tavares, BS.
The University of Texas Health Science Center at San Antonio Steven M. Haffner, MD1; 
Maria G. Montez, RN, MSHP, CDE2; Carlos Lorenzo, MD3.
University of Washington/VA Puget Sound Health Care System Steven E. Kahn, MB, 
ChB1; Brenda Montgomery, RN, MS, CDE2; Robert Knopp, MD3; Edward Lipkin, MD3; 
Matthew L. Maciejewski, PhD3; Dace Trence, MD3; Terry Barrett, BS; Joli Bartell, BA; 
Diane Greenberg, PhD; Anne Murillo, BS; Betty Ann Richmond, MEd; April Thomas, 
MPH, RD.
Southwestern American Indian Center, Phoenix, Arizona and Shiprock, New Mexico 
William C. Knowler, MD, DrPH1; Paula Bolin, RN, MC2; Tina Killean, BS2; Cathy Manus, 
LPN3; Jonathan Krakoff, MD3; Jeffrey M. Curtis, MD, MPH3; Justin Glass, MD3; Sara 
Michaels, MD3; Peter H. Bennett, MB, FRCP3; Tina Morgan3; Shandiin Begay, MPH; 
Bernadita Fallis RN, RHIT, CCS; Jeanette Hermes, MS, RD; Diane F. Hollowbreast; Ruby 
Johnson; Maria Meacham, BSN, RN, CDE; Julie Nelson, RD; Carol Percy, RN; Patricia 
Poorthunder; Sandra Sangster; Nancy Scurlock, MSN, ANP-C, CDE; Leigh A. Shovestull, 
RD, CDE; Janelia Smiley; Katie Toledo, MS, LPC; Christina Tomchee, BA; Darryl 
Tonemah PhD.
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University of Southern California Anne Peters, MD1; Valerie Ruelas, MSW, LCSW2; Siran 
Ghazarian Sengardi, MD2; Kathryn Graves, MPH, RD, CDE; Kati Konersman, MA, RD, 
CDE; Sara Serafin-Dokhan.
Coordinating Center
Wake Forest University Mark A. Espeland, PhD1; Judy L. Bahnson, BA2; Lynne 
Wagenknecht, DrPH3; David Reboussin, PhD3; W. Jack Rejeski, PhD3; Alain Bertoni, MD, 
MPH3; Wei Lang, PhD3; Gary Miller, PhD3; David Lefkowitz, MD3; Patrick S. Reynolds, 
MD3; Paul Ribisl, PhD3; Mara Vitolins, DrPH3; Michael Booth, MBA2; Kathy M. Dotson, 
BA2; Amelia Hodges, BS2; Carrie C. Williams, MA2; Jerry M. Barnes, MA; Patricia A. 
Feeney, MS; Jason Griffin, BS; Lea Harvin, BS; William Herman, MD, MPH; Patricia 
Hogan, MS; Sarah Jaramillo, MS; Mark King, BS; Kathy Lane, BS; Rebecca Neiberg, MS; 
Andrea Ruggiero, MS; Christian Speas, BS; Michael P. Walkup, MS; Karen Wall; Michelle 
Ward; Delia S. West, PhD; Terri Windham.
Central Resources Centers
DXA Reading Center, University of California at San Francisco Michael Nevitt, PhD1; 
Susan Ewing, MS; Cynthia Hayashi; Jason Maeda, MPH; Lisa Palermo, MS, MA; Michaela 
Rahorst; Ann Schwartz, PhD; John Shepherd, PhD.
Central Laboratory, Northwest Lipid Research Laboratories Santica M. Marcovina, PhD, 
ScD1; Greg Strylewicz, MS.
ECG Reading Center, EPICARE, Wake Forest University School of Medicine Ronald J. 
Prineas, MD, PhD1; Teresa Alexander; Lisa Billings; Charles Campbell, AAS, BS; Sharon 
Hall; Susan Hensley; Yabing Li, MD; Zhu-Ming Zhang, MD.
Diet Assessment Center, University of South Carolina, Arnold School of Public Health, 
Center for Research in Nutrition and Health Disparities Elizabeth J Mayer-Davis, PhD1; 
Robert Moran, PhD.
Hall-Foushee Communications, Inc.
Richard Foushee, PhD; Nancy J. Hall, MA.
Federal Sponsors
National Institute of Diabetes and Digestive and Kidney Diseases: Barbara Harrison, MS; 
Van S. Hubbard, MD PhD; Susan Z. Yanovski, MD.
National Heart, Lung, and Blood Institute: Lawton S. Cooper, MD, MPH; Jeffrey Cutler, 
MD, MPH; Eva Obarzanek, PhD, MPH, RD.
Centers for Disease Control and Prevention: Edward W. Gregg, PhD; David F. Williamson, 
PhD; Ping Zhang, PhD.
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Percentage of participants increasing consumption of low-fat food items from 0- to 12-
month in the Diabetes Support and Education (DSE) and Intensive Lifestyle Intervention 
(ILI) conditions. * P < 0.05.
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Table 4
Percentage of Look AHEAD participants with complete dietary assessments who met the dietary 
recommendations at 12 months (N = 2,397)
Nutrient Recommendation Diabetes Support & 
Education (n = 1,186)
Intensive Lifestyle 
Intervention (n = 1,211)
P-valuea
% energy from fat ≤ 30% 9.4 28.9 < 0.0001
% energy from saturated fat ≤ 10% 19.1 50.6 < 0.0001
Cholesterol ≤ 300 mg/day 60.3 79.9 < 0.0001
Bread, cereal, rice & pasta ≥ 6 servings/day 2.4 1.2 < 0.05
Fruit ≥ 2 servings/day 36.2 45.5 < 0.0001
Vegetable ≥ 3 servings/day 37.4 47.4 < 0.0001
Milk, yogurt & cheese ≥ 2 servings/day 35.1 72.4 < 0.0001
Meat, poultry, fish, dry beans, eggs & nuts ≥ 2 servings/day 54.1 36.3 < 0.0001
Fats, oils & sweets Limit, ≤ 1 serving/day 37.7 59.5 < 0.0001
a
P-values are for unadjusted Chi-square tests.
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